Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Patients with diabetes, multi-vessel coronary artery disease can benefit from bypass surgery

An international, clinical research trial has shown that patients with diabetes whose multi-vessel coronary artery disease is treated with bypass surgery live longer and are less likely to suffer severe complications like heart attacks than those who undergo angioplasty.

6 Nov 2012

Lifetime risks for total CVD are high regardless of index age

Even in men and women with an optimal cardiovascular disease (CVD) risk factor profile, the lifetime risk estimate for CVD is greater than 30 percent, and is more than 50 percent for men and women overall, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.

6 Nov 2012

Latinos, Hispanics in the U.S. more likely to develop major cardiovascular diseases

Hispanics and Latinos living in the U.S. are highly likely to have several major cardiovascular disease risk factors, such as high cholesterol, high blood pressure, obesity, diabetes, and smoking, according to a new, large-scale study. Risks vary among the diverse Hispanic/Latino groups, but individuals who were born in the U.S. are more likely to have multiple risk factors.

6 Nov 2012

Keeping cardiovascular disease risk factors low may lead to a longer, healthier life

If you have optimal heart health in middle age, you may live up to 14 years longer, free of cardiovascular disease, than your peers who have two or more cardiovascular disease (CVD) risk factors, according to a new Northwestern Medicine study.

6 Nov 2012

No link between daily multivitamin use and reduction of major cardiovascular events in men

In a randomized study that included nearly 15,000 male physicians who were middle-aged or older, daily multivitamin use for more than 10 years of treatment and follow-up did not result in a reduction of major cardiovascular events, heart attack, stroke, or death from cardiovascular disease, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.

5 Nov 2012

Anti-TNF-α therapy reduces CVD risk in patients with rheumatoid arthritis

Patients with rheumatoid arthritis exhibit a sub-clinical vasculitis that may underlie their increased risk for cardiovascular disease, shows research.

5 Nov 2012

Traditional CV risk factors linked to peripheral artery disease

Smoking, Type 2 diabetes, hypertension, and hypercholesterolemia are significantly associated with the risk for clinically significant peripheral artery disease in men, with each additional factor doubling the risk, conclude US and Dutch researchers.

5 Nov 2012

New studies support limiting daily sodium consumption to less than 1,500mg

New studies support limiting daily sodium consumption to less than 1,500 milligrams, according to a new American Heart Association presidential advisory.

3 Nov 2012

Near-complete blood flow restoration necessary to preserve neurological function following stroke

Two Rhode Island Hospital researchers recently found that restoring near-complete blood flow to the brain is necessary to restore or preserve neurological function following stroke. Seems like a no-brainer, right? Yet until their research was complete, many physicians and researchers believed that partial blood-flow restoration was good enough. Not anymore.

3 Nov 2012

State of glycocalyx barrier indicates vascular risk in dialysis patients

The glycocalyx barrier – a mesh of proteoglycans and associated glycosaminoglycans present on vascular endothelium – is impaired in patients with renal failure, probably contributing to their predisposition to endothelial dysfunction and vascular disease, say researchers.

2 Nov 2012

Driving up CVD event risk in diabetes

Professional drivers who have diabetes are at a significantly increased risk for a cardiovascular disease event compared with individuals with other occupations, report researchers.

2 Nov 2012

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.

2 Nov 2012

Antipsychotic drugs associated with increased mortality among people with schizophrenia

Results of a Johns Hopkins study suggest that individuals with schizophrenia are significantly more likely to live longer if they take their antipsychotic drugs on schedule, avoid extremely high doses and also regularly see a mental health professional.

2 Nov 2012

Apolipoprotein E plays a major role in maintaining arterial softness

Arterial stiffening has long been considered a major risk factor for cardiovascular disease. Keeping arteries soft and supple might reduce disease risk, but the mechanisms of how arteries stave off hardening has remained elusive.

2 Nov 2012

Cardio exercise OK in high-risk CVD patients

US study results indicate that cardiopulmonary exercise is well tolerated, even when performed by individuals with high-risk cardiovascular disease.

1 Nov 2012

FibroGen announces presentation of FG-4592 Phase 2 data on anemia at ASN Kidney Week 2012

FibroGen, Inc., today announced that two abstracts relating to FG-4592, its oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) clinical candidate for the treatment of anemia in chronic kidney disease, have been accepted for oral and poster presentations at the American Society of Nephrology (ASN) Kidney Week 2012.

1 Nov 2012

Regular exercise does not impact amount of time women spend sitting

Women who exercise regularly spend as much time sitting as women who don't, according to a new Northwestern Medicine study.

1 Nov 2012

Hormone therapy increases risk of heart attack or dying in women with metabolic syndrome

A new analysis of the Women's Health Initiative (WHI) trials show that women who had metabolic syndrome before they started hormone therapy had a greatly increased risk of heart attack or dying of heart disease. Women who didn't have metabolic syndrome beforehand showed no increased risk.

31 Oct 2012

Oily fish consumption may reduce risk of stroke

Eating at least two servings of oily fish a week is moderately but significantly associated with a reduced risk of stroke, finds a study published on bmj.com today.

31 Oct 2012

FDA accepts Sunovion’s two LATUDA sNDAs for review

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).

31 Oct 2012

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Patients with diabetes, multi-vessel coronary artery disease can benefit from bypass surgery

Lifetime risks for total CVD are high regardless of index age

Latinos, Hispanics in the U.S. more likely to develop major cardiovascular diseases

Keeping cardiovascular disease risk factors low may lead to a longer, healthier life

No link between daily multivitamin use and reduction of major cardiovascular events in men

Anti-TNF-α therapy reduces CVD risk in patients with rheumatoid arthritis

Traditional CV risk factors linked to peripheral artery disease

New studies support limiting daily sodium consumption to less than 1,500mg

Near-complete blood flow restoration necessary to preserve neurological function following stroke

State of glycocalyx barrier indicates vascular risk in dialysis patients

Driving up CVD event risk in diabetes

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

Antipsychotic drugs associated with increased mortality among people with schizophrenia

Apolipoprotein E plays a major role in maintaining arterial softness

Cardio exercise OK in high-risk CVD patients

FibroGen announces presentation of FG-4592 Phase 2 data on anemia at ASN Kidney Week 2012

Regular exercise does not impact amount of time women spend sitting

Hormone therapy increases risk of heart attack or dying in women with metabolic syndrome

Oily fish consumption may reduce risk of stroke

FDA accepts Sunovion’s two LATUDA sNDAs for review

Innovation in neuroscience drug discovery - eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in